Activated PI3KDELTA syndrome (APDS); pasli disease

Clinical trials for Activated PI3KDELTA syndrome (APDS); pasli disease explained in plain language.

Never miss a new study

Get alerted when new Activated PI3KDELTA syndrome (APDS); pasli disease trials appear

Sign up with your email to follow new studies for Activated PI3KDELTA syndrome (APDS); pasli disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental drug shows promise for rare immune disorder, but study cut short

Disease control Stopped early

This study tested the long-term safety and effectiveness of a drug called CDZ173 in people with APDS/PASLI, a rare genetic condition that causes a weak immune system and swollen lymph nodes. The 37 participants had already taken CDZ173 or a similar drug in a previous study. The t…

Matched conditions: ACTIVATED PI3KDELTA SYNDROME (APDS); PASLI DISEASE

Phase 2/3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC

Activated PI3KDELTA syndrome (APDS); pasli disease

Get alerted when new Activated PI3KDELTA syndrome (APDS); pasli disease trials appear

Experimental drug shows promise for rare immune disorder, but study cut short